Evidence map›Paper›PMID 42460216›Full record

ArticleCureus2026

FOXR2-Mediated CNS Neuroblastoma in a Pediatric Patient Treated With Multimodal Therapy Including Proton Craniospinal Irradiation: A Case Report.

Waseem Syed, Chetan Shah, Leticia Schaefer

Abstract readCase Reports
In one paragraph

Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Waseem SyedCollege of Medicine, Lake Erie College of Osteopathic Medicine, Bradenton, USA.
Chetan ShahPediatric Radiology, Nemours Children's Health System, Jacksonville, USA.
Leticia SchaeferRadiology, Nemours Children's Health System, Jacksonville, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

FOXR2-activated central nervous system (CNS) neuroblastoma is a rare embryonal tumor characterized by an aggressive nature, frequent leptomeningeal dissemination, and poor prognosis without intensive multimodal therapy. We report a four-year-old girl with multifocal FOXR2-altered CNS neuroblastoma treated with subtotal resection, multi-agent chemotherapy per ACNS0334, autologous stem cell transplant, and proton craniospinal irradiation (CSI) with focal boost. This case highlights modern management strategies and the rationale for proton therapy in reducing long-term treatment toxicity in very young children.

Indexed as

foxr2mrineuroblastomaproton therapyradiology

Identifiers

PMID42460216
PMCPMC13371507

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.